Therapeutic Evaluation of Polyherbal Formulation along with Olive oil in the Management of Chronic Urticaria.

Therapeutic and Safety Evaluation of A Compound Unani Formulation along with Roghan e Zaitoon in the Management of Shara (Chronic Urticaria) A Randomized open label Comparative clinical study. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094941

Enrollment

Registered

2025-09-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L50- Urticaria

Interventions

Intervention1: Compound Unani Formulation following ingredients 1.Faudanj (Mentha arvensis linn) 7gm 2. Tabasheer (Bambusa arundinac ea linn)3.5gm 3.Gule Surkh (Rosa domascen a mill) 1.75gm 4. Kaf

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically Diagnosed patients of Chronic Urticaria. 2. Mild to moderate grade as defined by the Urticaria activity score (UAS7) 3. Patient who are willing and able to comply with scheduled visit and treatment plan, laboratory testing. and other study procedure.

Exclusion criteria

Exclusion criteria: 1. Patients having any cardiac, renal, and or hepatic insufficiency. 2. Patient with current diagnosis of active skin disease e.g. psoriasis, lupus erythematosus Allergic dermatoses, eczema etc. 3. Pregnant and lactating women. 4. Patient unwilling to cooperate with the study protocol. 5. Patient taking either systemic or local corticosteroid.

Design outcomes

Primary

Measure	Time frame
Urticaria Activity Score (UAS7)Timepoint: On Day 0,7,14,21 and 28.	—

Secondary

Measure	Time frame
DLQI (Dermatology life quality index)Timepoint: On Day 0 and 28.	—

Countries

India

Contacts

Public ContactAsma Md Abid

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital

dilshadali28@gmail.com831976821

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026